Harvard Apparatus Regenerative Technology Inc Revenue Growth Rates (BSTG), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Harvard Apparatus Regenerative Technology Inc   (BSTG)
 

BSTG's Revenue Growth by Quarter and Year

Harvard Apparatus Regenerative Technology Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BSTG Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 0.23
FY 0.23





BSTG Revenue first quarter 2026 Y/Y Growth Comment
Harvard Apparatus Regenerative Technology Inc achieved in the first quarter 2026, above Company average Revenue surge of 352% year on year, to $ 0.23 millions.

Looking into first quarter 2026 results within Medical Equipment & Supplies industry 123 other companies have achieved higher Revenue growth. While Harvard Apparatus Regenerative Technology Inc ' s Revenue doubling of 352% ranks overall at the positon no. 2397 in the first quarter 2026.


BSTG Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - -15.38 % 333.33 % -
3rd Quarter September - 100 % 50 % -
2nd Quarter June - 433.33 % - -
1st Quarter March 352 % -16.67 % - -
FY   - 61.36 % 340 % -

Financial Statements
Harvard Apparatus Regenerative Technology Inc 's first quarter 2026 Revenue $ 0.23 millions BSTG's Income Statement
Harvard Apparatus Regenerative Technology Inc 's first quarter 2025 Revenue $ 0.05 millions Quarterly BSTG's Income Statement


BSTG Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 83.33 % 333.33 % 50 %
3rd Quarter September - -62.5 % 0 % -
2nd Quarter June - 540 % 0 % -
1st Quarter March 2.73 % -80.77 % 0 % -
FY (Year on Year)   - 61.36 % 340 % -


Back to BSTG Growth rate Comparisons >> Back to BSTG Growth rate Comparisons >>


Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #124
Healthcare Sector #355
Overall #2397

Revenue Y/Y Growth Statistics
High Average Low
216.17 % 151.49 % 63.72 %
(Sep 30 2025)   (Dec 31 2025)
Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #124
Healthcare Sector #355
Overall #2397
Revenue Y/Y Growth Statistics
High Average Low
216.17 % 151.49 % 63.72 %
(Sep 30 2025)   (Dec 31 2025)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Harvard Apparatus Regenerative Technology Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
604.44 % 63.95 % -100 %
(Jun 30 2025)  


BSTG's I. Quarter Q/Q Revenue Comment
Harvard Apparatus Regenerative Technology Inc achieved in the I. Quarter 2026 below company average Revenue growth of 2.73% quarter on quarter, to $ 0.23 millions.

Although the I. Quarter 2026 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the I. Quarter surge, eclipses the -80.77% growth in the I. Quarter a year ago

Within Medical Equipment & Supplies industry 32 other companies have achieved higher Revenue quarter on quarter growth. While Harvard Apparatus Regenerative Technology Inc 's Revenue growth quarter on quarter, overall rank is 973.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #33
Healthcare Sector #140
Overall #973
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #33
Healthcare Sector #140
Overall #973
Revenue Q/Q Growth Statistics
High Average Low
604.44 % 63.95 % -100 %
(Jun 30 2025)  


BSTG's I. Quarter Q/Q Revenue Comment
Harvard Apparatus Regenerative Technology Inc achieved in the I. Quarter 2026 below company average Revenue growth of 2.73% quarter on quarter, to $ 0.23 millions.

I. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -80.77% in the I. Quarter a year ago.

Within Medical Equipment & Supplies industry 32 other companies have achieved higher Revenue quarter on quarter growth. While Harvard Apparatus Regenerative Technology Inc 's Revenue growth quarter on quarter, overall rank is 973.


Harvard Apparatus Regenerative Technology Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)		 12 Months Ending
(Mar 31 2025)
Cumulative Revenue 12 Months Ending $ 0.89 $ 0.70 $ 0.74 $ 0.68 $ 0.42
Y / Y Revenue Growth (TTM) 111.72 % 63.72 % 216.17 % 214.35 % -
Year on Year Revenue Growth Overall Ranking # 65 # 43 # 29 # 43 # 0
Seqeuential Revenue Change (TTM) 25.71 % -5.25 % 9.43 % 62.44 % -2.79 %
Seq. Revenue Growth (TTM) Overall Ranking # 2397 # 112 # 873 # 1050 # 997


Cumulative Revenue growth Comment
Although Harvard Apparatus Regenerative Technology Inc 's Annual Revenue growth year on year were below company's average 151.49% , Revenue announced in the Mar 31 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 111.72% year on year, from 63.72% in Dec 31 2025.

Within the Healthcare sector 22 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 43 to 65.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 124
Healthcare Sector # 23
Overall # 65

Revenue TTM Y/Y Growth Statistics
High Average Low
216.17 %
 151.49 %
63.72 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 124
Sector # 355
S&P 500 # 2397
Cumulative Revenue growth Comment
Although Harvard Apparatus Regenerative Technology Inc 's Annual Revenue growth year on year were below company's average 151.49% , Revenue announced in the Mar 31 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 111.72% year on year, from 63.72% in Dec 31 2025.

Within the Healthcare sector 22 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 43 to 65.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 124
Healthcare Sector # 23
Overall # 65

Revenue TTM Y/Y Growth Statistics
High Average Low
216.17 %
151.49 %
63.72 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 124
Sector # 355
S&P 500 # 2397




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BSTG's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Mar 31 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2026
Safe Pro Group Inc 560.24%$ 560.236 millions
Dar Bioscience Inc 499.58%$ 499.579 millions
Scienture Holdings Inc 449.08%$ 449.084 millions
Surrozen Inc 408.65%$ 408.647 millions
Harvard Apparatus Regenerative Technology Inc 402.22%$ 402.222 millions
Nakamoto Inc 362.00%$ 361.999 millions
Vireo Growth Inc.333.47%$ 333.469 millions
Xilio Therapeutics Inc 331.67%$ 331.672 millions
Beam Therapeutics Inc 324.87%$ 324.873 millions
Wave Life Sciences Ltd 316.85%$ 316.850 millions
Insmed Inc301.22%$ 301.215 millions
Volitionrx Limited299.81%$ 299.812 millions
Star Equity Holdings Inc 287.35%$ 287.349 millions
Moderna Inc 260.19%$ 260.185 millions
Omniab Inc 247.30%$ 247.304 millions
Protalix Biotherapeutics inc 233.73%$ 233.729 millions
Pavmed Inc 225.00%$ 225.000 millions
Syndax Pharmaceuticals Inc 223.64%$ 223.640 millions
Catheter Precision Inc 202.10%$ 202.098 millions
Silence Therapeutics Plc197.18%$ 197.183 millions
Autolus Therapeutics Plc191.89%$ 191.895 millions
Co diagnostics Inc 190.30%$ 190.300 millions
Renovorx Inc 185.79%$ 185.787 millions
Cardio Diagnostics Holdings Inc 185.11%$ 185.106 millions
Ars Pharmaceuticals Inc 184.47%$ 184.473 millions
Tonix Pharmaceuticals Holding Corp 183.16%$ 183.162 millions
Dyadic International Inc 182.28%$ 182.275 millions


About Harvard Apparatus Regenerative Technology Inc Revenue Growth Rates (BSTG), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Harvard Apparatus Regenerative Technology Inc (CIK 1563665).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-26-027566
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Harvard Apparatus Regenerative Technology Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.